COMMODORE CAPITAL LP's portfolio and holdings - Apr 2026

As per corporate shareholdings filed for Mar-2026, people matching COMMODORE CAPITAL LP publicly holds 39 stocks with a net worth of over US$ 2.5 B.

These are shares held by COMMODORE CAPITAL LP as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.

Month Ending
FOLLOW ALL SUPERSTARS
Stock Name Holders Name Current Price US$ Quantity Held Holding Percent Change from Previous Qtr Holding Value US$ History
Relay Therapeutics Inc Commodore Capital Lp 12.72 17,000,000 8.88% -0.63 216.2 M
Enliven Therapeutics Inc Commodore Capital Lp 41.70 4,692,809 7.71% -0.14 195.7 M
Harpoon Therapeutics Inc Commodore Capital Lp 23.01 1,500,000 7.01% NEW 34.5 M
Palisade Bio Inc Commodore Capital Lp 1.99 11,445,000 6.83% NEW 22.8 M
Assembly Biosciences Inc Commodore Capital Lp 27.37 1,000,000 6.29% -0.03 27.4 M
SAB Biotherapeutics Inc Commodore Capital Lp 3.47 4,401,500 6.26% -2.98 15.3 M
Tyra Biosciences Inc Commodore Capital Lp 34.04 3,375,000 5.67% -0.65 114.9 M
LB Pharmaceuticals Inc Commodore Capital Lp 31.43 1,500,000 5.23% -0.70 47.1 M
Alto Neuroscience Inc. Commodore Capital Lp 24.94 1,823,196 5.20% NEW 45.5 M
Ambrx Biopharma Inc - ADR Commodore Capital Lp 0.00 3,175,000 5.12% -2.80 -
Amylyx Pharmaceuticals Inc Commodore Capital Lp 16.01 5,650,000 5.09% 1.40 90.5 M
LeonaBio Inc. Commodore Capital Lp 8.82 464,398 4.94% NEW 4.1 M
PepGen Inc Commodore Capital Lp 1.75 3,400,000 4.92% 1.49 6.0 M
Merus N.V Commodore Capital Lp 90.00 3,525,000 4.65% 0.00 317.3 M
Inhibikase Therapeutics Inc Commodore Capital Lp 1.91 5,397,488 4.09% -0.36 10.3 M
CytomX Therapeutics Inc Commodore Capital Lp 4.18 7,692,300 3.56% -0.98 32.2 M
Celldex Therapeutics Inc. Commodore Capital Lp 32.31 2,565,000 3.27% -1.28 82.9 M
Oruka Therapeutics Inc. Commodore Capital Lp 62.58 1,753,054 2.93% -0.69 109.7 M
Spyre Therapeutics Inc. Commodore Capital Lp 69.42 2,388,245 2.77% 0.24 165.8 M
Alpine Immune Sciences Inc Commodore Capital Lp 7.80 1,610,000 2.46% 0.43 12.6 M
Soleno Therapeutics Inc Commodore Capital Lp 52.87 1,200,000 2.32% -0.29 63.4 M
Nurix Therapeutics Inc Commodore Capital Lp 16.81 2,275,000 2.20% -1.48 38.2 M
Contineum Therapeutics Inc. - Ordinary Shares - Class A Commodore Capital Lp 13.20 816,326 2.19% NEW 10.8 M
Alkermes plc Commodore Capital Lp 33.38 3,550,000 2.14% 0.28 118.5 M
Xenon Pharmaceuticals Inc Commodore Capital Lp 56.13 1,800,000 1.86% -1.38 101.0 M
Cidara Therapeutics Inc Commodore Capital Lp 221.38 585,000 1.86% -14.81 129.5 M
Mind Medicine Inc Commodore Capital Lp 21.70 2,000,000 1.83% -1.40 43.4 M
Avalo Therapeutics Inc Commodore Capital Lp 13.71 483,000 1.81% -0.80 6.6 M
Replimune Group Inc Commodore Capital Lp 2.50 1,425,000 1.73% NEW 3.6 M
Cogent Biosciences Inc Commodore Capital Lp 36.63 2,196,845 1.29% -3.18 80.5 M
Terns Pharmaceuticals Inc Commodore Capital Lp 52.93 1,475,000 1.28% -3.96 78.1 M
Kymera Therapeutics Inc Commodore Capital Lp 80.71 750,000 0.91% -0.01 60.5 M
RAPT Therapeutics Inc Commodore Capital Lp 58.02 250,000 0.86% NEW 14.5 M
Protagonist Therapeutics Inc Commodore Capital Lp 98.37 450,000 0.70% -0.91 44.3 M
Nuvalent Inc - Ordinary Shares - Class A Commodore Capital Lp 99.04 550,000 0.70% -1.08 54.5 M
Centessa Pharmaceuticals plc - ADR Commodore Capital Lp 39.57 1,000,000 0.65% -1.28 39.6 M
RayzeBio Inc. Commodore Capital Lp 62.49 383,638 0.64% NEW 24.0 M
Aeglea BioTherapeutics Inc Commodore Capital Lp 69.42 116,324 0.32% -2.55 8.1 M
Bright Minds Biosciences Inc Commodore Capital Lp 86.96 18,851 0.19% -4.92 1.6 M
View All The Superstar Shareholder Portfolios